![]() | |
Identifiers | |
---|---|
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C20H25ClN2O2 |
Molar mass | 360.88 g·mol−1 |
3D model (JSmol) | |
| |
|
Mefeclorazine (INN ) is a neuroleptic (antipsychotic) of the phenethylamine and arylpiperazine groups. [1] [2] [3]
Part of mefeclorazine's chemical structure is based on 3,4-dimethoxyphenethylamine (DMPEA or homoveratrylamine), which has structural similarity to the neurotransmitter dopamine. [1] Mefeclorazine was invented by Jack Mills of Eli Lilly in 1958. [4] Although it is not known to have ever been used clinically, [1] it is based on a chemically rational synthetic design.
The ortho-chlorophenylpiperazine (oCPP) moiety forms part of the molecular structure. [1] This precursor finds dual use in the synthesis of the arylpiperazines enpiprazole and KMUP-1.[ citation needed ]
Mefeclorazine, INN 1-(2-Chlorophenyl)-4-(3,4-dimethoxyphenethyl)-piperazine. SD 218-06 [1243-33-0] [...] C20H25ClN202 M 360.883 M-00061 Neuroleptic agent. [...]